Norovirus Virus-Like Particle Vaccine from Japan
Virus-like particle (VLP) vaccine mimicking norovirus capsids for gastrointestinal prophylaxis. HTS 3002.49.0050 covers this as other biotechnologically obtained similar product for human vaccination, excluding yeasts.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Declare VLP production method (e.g
• insect cells); maintain 2-8°C chain
• Submit stability and immunogenicity data; avoid bulk unpackaged forms